BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33823519)

  • 1. Screening a Prognosis-Related Target Gene in Patients with HER-2-Positive Breast Cancer by Bioinformatics Analysis.
    Wang S; Deng J; Gao X; Lv H; Quan Y
    Med Princ Pract; 2021; 30(4):376-384. PubMed ID: 33823519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis.
    Lin Y; Fu F; Lv J; Wang M; Li Y; Zhang J; Wang C
    Medicine (Baltimore); 2020 Jan; 99(1):e18445. PubMed ID: 31895772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
    Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
    Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanism of RRM2 for promoting Cervical Cancer based on weighted gene co-expression network analysis.
    Wang J; Yi Y; Chen Y; Xiong Y; Zhang W
    Int J Med Sci; 2020; 17(15):2362-2372. PubMed ID: 32922202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis revealing prognostic significance of
    Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
    Vastrad B; Vastrad C; Tengli A; Iliger S
    Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis.
    Chen G; Yu M; Cao J; Zhao H; Dai Y; Cong Y; Qiao G
    Bioengineered; 2021 Dec; 12(1):5149-5161. PubMed ID: 34384030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
    Tang D; Zhao X; Zhang L; Wang Z; Wang C
    J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value.
    Zhou Y; Yang L; Zhang X; Chen R; Chen X; Tang W; Zhang M
    Biomed Res Int; 2019; 2019():6581576. PubMed ID: 31119182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of Prognostic Factors in Early-Onset Breast Cancer.
    Yu Z; He Q; Xu G
    Technol Cancer Res Treat; 2020; 19():1533033819893670. PubMed ID: 32028860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
    Wu J; Zhang Y; Li M
    J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Four Pathological Stage-Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
    Xu D; Xu Y; Lv Y; Wu F; Liu Y; Zhu M; Chen D; Bai B
    Biomed Res Int; 2020; 2020():2137319. PubMed ID: 32309427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential prognostic biomarkers for breast cancer using WGCNA and PPI integrated techniques.
    Zheng G; Zhang C; Zhong C
    Ann Diagn Pathol; 2021 Feb; 50():151675. PubMed ID: 33291061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
    Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X
    Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of critical genes associated with poor prognosis in breast cancer via integrated bioinformatics analyses.
    Liu D; Zhang J; Li L; Wang Q; Lan Y
    J BUON; 2020; 25(6):2537-2545. PubMed ID: 33455094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis.
    Ding YG; Ren YL; Xu YS; Wei CS; Zhang YB; Zhang SK; Guo CA
    Am J Otolaryngol; 2020; 41(3):102434. PubMed ID: 32093976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.